ISDA letter to ESMA and NCAs on OTC challenges for EMIR reporting – update

ISDA letter to ESMA and National Competent Authorities (NCAs) providing an update on anticipated challenges for EMIR reporting of OTC Derivatives from February 12, 2014.

Appendix 1: Update on each of the industry issues and challenges advised previously (Appendix 2).
Appendix 2: Original list of industry issues and challenges.

Market Transformation – IQ May 2026

On the 250th anniversary of American independence, this year’s ISDA Annual General Meeting (AGM) was held in Boston, a city that played a prominent role in the American Revolution. In his opening remarks, ISDA chief executive Scott O’Malia drew a...

Letter to EC and ESMA on Derivatives Framework

On March 27, ISDA sent a letter to the European Commission (EC) and the European Securities and Markets Authority (ESMA) to highlight several technical issues arising from the interaction between the delegated regulation (EU) 2025/1003 on identifying reference data to...